Semi-Annual Statement Of Income And Retained Earnings

Daito Pharmaceutical Co., Ltd. - Filing #7588003

Concept 2022-06-01 to
2022-08-31
2021-06-01 to
2021-08-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
1,501,000,000 JPY
2,360,000,000 JPY
Non-operating income
Non-operating income
36,000,000 JPY
73,000,000 JPY
Non-operating expenses
Non-operating expenses
62,000,000 JPY
13,000,000 JPY
Ordinary profit (loss)
1,475,000,000 JPY
2,419,000,000 JPY
Extraordinary income
Extraordinary income
JPY
246,000,000 JPY
Extraordinary losses
Extraordinary losses
4,000,000 JPY
24,000,000 JPY
Profit (loss) before income taxes
1,470,000,000 JPY
2,642,000,000 JPY
Profit (loss)
926,000,000 JPY
1,817,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.